83 related articles for article (PubMed ID: 18600104)
1. Low prevalence of the JAK2V617F in patients with ischemic stroke or cerebral venous thrombosis.
Xavier SG; Gadelha T; Schaffel R; Britto L; Pimenta G; Ribeiro DD; Sabino Ade P; Pires V; Renault IZ; Spector N
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):468-9. PubMed ID: 18600104
[No Abstract] [Full Text] [Related]
2. The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.
Bellucci S; Cassinat B; Bonnin N; Marzac C; Crassard I
Thromb Haemost; 2008 Jun; 99(6):1119-20. PubMed ID: 18521518
[No Abstract] [Full Text] [Related]
3. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population.
Uçar F; Sönmez M; Ovali E; Ozmenoglu M; Karti SS; Yilmaz M; Pakdemir A
Am J Hematol; 2004 May; 76(1):40-3. PubMed ID: 15114595
[TBL] [Abstract][Full Text] [Related]
4. JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases.
Godeneche G; Gaillard N; Roy L; Mania A; Tondeur S; Chomel JC; Lavabre T; Arquizan C; Neau JP
Cerebrovasc Dis; 2010 Jan; 29(2):206-9. PubMed ID: 20029191
[No Abstract] [Full Text] [Related]
5. The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal.
De Stefano V; Rossi E; Za T; Chiusolo P; Leone G
Thromb Haemost; 2008 Jun; 99(6):1121. PubMed ID: 18521519
[No Abstract] [Full Text] [Related]
6. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
Herak DC; Antolic MR; Krleza JL; Pavic M; Dodig S; Duranovic V; Brkic AB; Zadro R
Pediatrics; 2009 Apr; 123(4):e653-60. PubMed ID: 19336355
[TBL] [Abstract][Full Text] [Related]
7. Is the JAK2 V617F mutation a hallmark for different forms of thrombosis?
Zerjavic K; Zagradisnik B; Stangler Herodez S; Lokar L; Glaser Krasevac M; Kokalj Vokac N
Acta Haematol; 2010; 124(1):49-56. PubMed ID: 20616539
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke.
Joly B; Menard AL; Ozkul-Wermester O; Triquenot-Bagan A; Guegan-Massardier E; Borg JY; Le Cam-Duchez V
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):916-7. PubMed ID: 25360683
[No Abstract] [Full Text] [Related]
9. Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population.
Somarajan BI; Kalita J; Mittal B; Misra UK
J Neurol Sci; 2011 May; 304(1-2):67-70. PubMed ID: 21406306
[TBL] [Abstract][Full Text] [Related]
10. The tissue factor pathway inhibitor C536T mutation is not associated with the risk of stroke in young adults.
Junker R; Glahn J; Tidow N; Brinkmann T; Nabavi DG
Thromb Haemost; 2002 May; 87(5):920-1. PubMed ID: 12038800
[No Abstract] [Full Text] [Related]
11. TFPI gene variation and ischemic stroke.
Pedersen A; Hanson E; Olsson S; Stanne TM; Blomstrand C; Melander O; Lindgren A; Jood K; Jern C
Thromb Res; 2012 Sep; 130(3):565-7. PubMed ID: 22749962
[No Abstract] [Full Text] [Related]
12. Methylenetetrahydrofolate reductase gene polymorphism and childhood stroke.
Morita DC; Donaldson A; Butterfield RJ; Benedict SL; Bale JF
Pediatr Neurol; 2009 Oct; 41(4):247-9. PubMed ID: 19748043
[TBL] [Abstract][Full Text] [Related]
13. Association between kinase insert domain-containing receptor gene polymorphism and haplotypes and ischemic stroke.
Oh SH; Min KT; Jeon YJ; Kim MH; Moon JS; Kim HS; Kim WC; Kim OJ; Park EK; Kim NK
J Neurol Sci; 2011 Sep; 308(1-2):62-6. PubMed ID: 21705026
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.
Orr DW; Patel RK; Lea NC; Westbrook RH; O'Grady JG; Heaton ND; Pagliuca A; Mufti GJ; Heneghan MA
Aliment Pharmacol Ther; 2010 Jun; 31(12):1330-6. PubMed ID: 20331577
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
Grandone E; Colaizzo D; Tiscia GL; Vergura P; Chinni E; Iannaccone L; Antinolfi I; Guardascione MA; Margaglione M
Thromb Haemost; 2008 Mar; 99(3):640-2. PubMed ID: 18327418
[No Abstract] [Full Text] [Related]
16. Prevalence of the JAK2 V617F and MPL mutations in stroke, abdominal and peripheral venous thrombosis.
McCarthy N; McCarron SL; Langabeer SE
Acta Haematol; 2010; 124(3):160-1. PubMed ID: 20938171
[No Abstract] [Full Text] [Related]
17. Genetic variants on chromosome 9p21 and ischemic stroke in Chinese.
Hu WL; Li SJ; Liu DT; Wang Y; Niu SQ; Yang XC; Zhang Q; Yu SZ; Jin L; Wang XF
Brain Res Bull; 2009 Aug; 79(6):431-5. PubMed ID: 19559344
[TBL] [Abstract][Full Text] [Related]
18. A lack of association of variants in Hemochromatosis gene with ischemic stroke.
Saleheen D; Farooq U; Frossard P
Med Sci Monit; 2005 Sep; 11(9):LE9. PubMed ID: 16127372
[No Abstract] [Full Text] [Related]
19. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.
Patnaik MM; Knudson RA; Gangat N; Hanson CA; Pardanani A; Tefferi A; Ketterling RP
Eur J Haematol; 2010 Jun; 84(6):518-24. PubMed ID: 20331734
[TBL] [Abstract][Full Text] [Related]
20. Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation.
Swaminathan S; Madkaikar M; Ghosh K; Vundinti BR; Kerketta L; Gupta M
Eur J Haematol; 2010 Feb; 84(2):180-2. PubMed ID: 19824900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
